Genotoxicity of cisplatin

Many cancers are treated with DNA-damaging drugs. But one, testicular cancer, responds so well to the drug cisplatin that the cure rate for early-stage disease is about 100%. Even if the cancer has spread to nearby lymph nodes, there is a five-year survival of 74%. What makes this combination of a particular drug and cell type so unique?